Marsh & McLennan Companies (MMC)
(Delayed Data from NYSE)
$224.66 USD
-2.26 (-1.00%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $224.64 -0.02 (-0.01%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$224.66 USD
-2.26 (-1.00%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $224.64 -0.02 (-0.01%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
Zacks News
Willis Towers (WLTW) Q2 Earnings & Revenues Top, Dividend Up
by Zacks Equity Research
Willis Towers (WLTW) Q2 results reflect broad-based revenue growth, continued margin expansion, and significant bottom line growth
The Zacks Analyst Blog Highlights: Nike, General Motors, Marsh & McLennan, Capital One Financial and Intuitive Surgical
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Nike, General Motors, Marsh & McLennan, Capital One Financial and Intuitive Surgical
U.S. Economy Exceeds Pre-Pandemic Level: 5 Top Picks
by Nalak Das
We have narrowed down our search to five corporate giants that have seen positive earnings estimate revisions for 2021 within the last 7 days. These are: GM, NKE, MMC, ISRG and COF.
Willis Towers Watson (WLTW) and AON Merger Falls Apart
by Zacks Equity Research
Willis Towers (WLTW) and AON's merger falls apart as U.S. Department of Justice anticipates that the merger could threaten competition.
What Awaits Arthur J. Gallagher (AJG) This Earnings Season?
by Zacks Equity Research
Arthur J. Gallagher's (AJG) Q2 results are likely to reflect strong EBITDAC growth, increase in covered lives and special project work as well as higher property and casualty rates.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Marsh & McLennan's (MMC) Q2 Earnings Beat, Rise Y/Y
by Zacks Equity Research
Marsh & McLennan's (MMC) Q2 earnings gain from better revenues at both its Risk and Insurance Services and Consulting segments.
Marsh & McLennan (MMC) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Marsh & McLennan (MMC) delivered earnings and revenue surprises of 23.24% and 12.87%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Why Marsh & McLennan (MMC) Might Surprise This Earnings Season
by Zacks Equity Research
Marsh & McLennan (MMC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What's in Store for Marsh & McLennan's (MMC) Q2 Earnings?
by Zacks Equity Research
Marsh & McLennan's (MMC) second-quarter results are likely to reflect better revenues and a solid contribution made by its Risk and Insurance Services as well as Consulting segments.
Marsh & McLennan (MMC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Marsh & McLennan (MMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
7 Insurers That Are Likely to Deliver Q2 Earnings Beat
by Tanuka De
Better pricing, exposure growth, redesigning of products and sturdy capital are expected to help AXS, NMIH, MET, ATH, VOYA, MMC, and AFL outperform Q2 earnings estimates.
Arthur J. Gallagher (AJG) Buys Rest of Edelweiss Shares
by Zacks Equity Research
Arthur J. Gallagher (AJG) acquires the residual interest in Edelweiss Gallagher to reinforce its footprint in India.
First American (FAF) Completes Buyout of Georgetown Title
by Zacks Equity Research
First American Financial (FAF) acquires Georgetown Title to expand its global footprint and enhance its title insurance business.
Arthur J. Gallagher (AJG) Announces Stellar Benefits Buyout
by Zacks Equity Research
Arthur J. Gallagher (AJG) acquires Stellar Benefits to boost its benefits capabilities throughout Northeastern Ohio.
Should You Retain Willis Towers (WLTW) in Your Portfolio?
by Zacks Equity Research
Willis Towers (WLTW) is poised to benefit from global benefit management, advisory services across various lines of business and effective capital deployment.
MMC vs. BRO: Which Stock is Better Placed for Your Portfolio?
by Zacks Equity Research
Brown & Brown (BRO) and Marsh & McLennan (MMC) are poised to grow in the thriving insurance brokerage space. Based on certain parameters, we try to find out which stock is better than the other.
Arthur J. Gallagher (AJG) Announces Excess Underwriting Buyout
by Zacks Equity Research
Arthur J. Gallagher (AJG) acquires Excess Underwriting Company to unveil products in the Canadian marketplace.
Assurant (AIZ) Buys Remainder of Olivar, Boosts Mobile Solution
by Zacks Equity Research
Assurant (AIZ) buys remaining shares in Olivar to reinforce its footprint in the Asia Pacific region and strengthen its global asset disposition services.
Arthur J. Gallagher (AJG) Buys Remainder of Hesse & Partner
by Zacks Equity Research
Arthur J. Gallagher (AJG) acquires Hesse & Partner to strengthen its presence in Europe.
Arthur J. Gallagher (AJG) Up 52% in a Year: More Upside Left?
by Zacks Equity Research
Strong results at Brokerage and Risk Management segments and solid cash flows continue to aid Arthur J. Gallagher (AJG).
Reasons to Add Brown & Brown (BRO) Stock to Your Portfolio
by Zacks Equity Research
Brown & Brown's (BRO) impressive growth is driven by organic and inorganic means across all segments.
Marsh & McLennan's (MMC) Unit Surpasses the $390 Billion Mark
by Zacks Equity Research
Marsh & McLennan's (MMC) subsidiary crosses the $390-billion mark in assets under management (AUM).
Why Should You Add Nasdaq (NDAQ) Stock to Your Portfolio?
by Zacks Equity Research
Nasdaq's (NDAQ) significant and leading positions in large, high growth markets like Index, Analytics, Market Technology, and IR & ESG Services bode well for growth.
Why Should You Add Marsh & McLennan (MMC) to Your Portfolio?
by Zacks Equity Research
Banking on revenue growth and judicious strategic actions, Marsh & McLennan (MMC) holds promises to be an attractive bet for yield-seeking investors.